Lv75
4160 积分 2021-05-25 加入
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
9天前
已完结
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
28天前
已完结
Pembrolizumab plus chemotherapy for advanced gastric cancer
28天前
已完结
New paradigm for expediting drug development in Asia
2个月前
已完结
Oncology Therapy Drugs in China, Japan, and the United States: Pharmacokinetic Characteristics, Dose Regimens, and Development Strategies
2个月前
已完结
Racial and Ethnic Differences in Drug Disposition and Response: Review of New Molecular Entities Approved Between 2014 and 2019
2个月前
已完结
Surveys/Research Exploring Japanese Phase I Studies in Global Drug Development: Are They Necessary Prior to Joining Global Clinical Trials?
2个月前
已完结
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
7个月前
已完结
U3-1402 sensitizes HER3-expressing tumors to PD-1 blockade by immune activation
10个月前
已完结
Evolutionary characterization of lung adenocarcinoma morphology in TRACERx
1年前
已完结
